Health and wellness company Hims & Hers announced Monday that it is introducing injectable weight-loss drugs at a fraction of the cost of Ozempic and Wegovy.
Health platform Hims & Hers Health Inc. announced Monday that it's rolling out injectable weight-loss drugs that cost a fraction of the price of competitors Wegovy and Ozempic. Hims & Hers says its GLP-1 medications contain the same active ingredients as its rivals, but the price starts at $199 per month. For comparison, Wegovy costs around $1,350 per month, and Ozempic is priced at around $935 without insurance. Novo Nordisk produces both drugs.
In 2023, one in 60 adults were prescribed a GLP-1 medication, according to the American Pharmacists Association. By 2030, the number of GLP-1 users in the U.S. could reach 30 million, or around 9% of the overall population, according to JPMorgan. The market is projected to exceed $100 billion by that same year, "driven equally by diabetes and obesity usage," the firm noted.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
US Senate committee investigates pricing of Novo's Ozempic and WegovyUS Senate committee investigates pricing of Novo's Ozempic and Wegovy
Read more »
Senate launches investigation into high prices of Ozempic and Wegovy in the U.S.Before insurance, Novo Nordisk charges about $1,000 per month for Ozempic in the United States. In Germany, the company charges $59 a month for the same drug.
Read more »
US Senate committee investigates pricing of Novo's Ozempic and WegovyA U.S. Senate committee said on Wednesday it had launched an investigation into the prices of Novo Nordisk's diabetes and weight loss drugs Ozempic and Wegovy in the United States.
Read more »
Sen. Bernie Sanders launches Senate investigation into 'high' pricing of Ozempic, WegovySenator Berne Sanders is launching an investigation into the 'outrageously high prices' Novo Nordisk charges for the drugs.
Read more »
Sen. Bernie Sanders launches Senate investigation into 'high' pricing of Ozempic, WegovySenator Berne Sanders is launching an investigation into the 'outrageously high prices' Novo Nordisk charges for the drugs.
Read more »
Sen. Bernie Sanders launches Senate investigation into 'high' pricing of Ozempic, WegovySenator Berne Sanders is launching an investigation into the 'outrageously high prices' Novo Nordisk charges for the drugs.
Read more »